Connectoma Neurotech

📍 Madrid, Spain👥 4 employees💰 Last funded Jun 2025
Mental Health Care
LinkedIn
At Connectoma, were revolutionizing mental health care with advanced AI and neurotechnology solutions. By mapping individual neural connections through AI-driven fMRI analysis, we provide precise diagnoses and personalized transcranial magnetic stimulation (TMS) treatments for complex conditions such as treatment-resistant depression, PTSD, chronic pain, and addictions. Join us in transforming lives and redefining the future of mental wellness. Why Connectoma? - Cutting-Edge Technology: Leveraging AI-driven fMRI analysis to understand the unique neural pathways of each individual. - Personalized Treatments: Delivering tailored TMS therapies that address specific mental health challenges effectively. - Impactful Results: Aiming to improve outcomes for those suffering from the most resistant and challenging mental health conditions. Be part of the revolution in mental health care. Together, were reshaping lives and pioneering a new future for mental wellness.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Andorra
1
Frequently asked questions
Who invested in Connectoma Neurotech?
Connectoma Neurotech has 1 investors on record on gritt.io.
When did Connectoma Neurotech last raise funding?
The most recent investment in Connectoma Neurotech recorded on gritt.io was in June 2025.
What industry is Connectoma Neurotech in?
Connectoma Neurotech operates in Mental Health Care. Find similar Mental Health Care investors on gritt.io.
Where is Connectoma Neurotech based?
Connectoma Neurotech is headquartered in Madrid, Spain.